Home
Index Entries
Topics
Glossary
About
Contact
Topics
heart disorders
Information Sources addressing Topic
A case of fatal multi-organ inflammation following COVID-19 vaccination
A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products
A Systematic Review of Autopsy Findings in Deaths after COVID-19 Vaccination
A Systematic Review of COVID-19 Vaccine-Induced Takotsubo Cardiomyopathy: A 2023 Update
Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning
Abstract 10712: Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines
Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study
Advisory Committee on Vaccines (Australia) - Meeting 22 - Minutes on Item 2.1 - BNT162b2 [mRNA] COVID-19 vaccine
Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccination
Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries
Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches
Assessment of cardiac adverse events following COVID‑19 vaccination by speckle tracking echocardiography
Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children
Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues
Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis
Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose
Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination
BNT162b2 Vaccine-Associated Myo/Pericarditis in Adolescents: A Stratified Risk-Benefit Analysis
Briefing Document: Vaccines and Related Biological Products Advisory Committee Meeting 2021-10-26
Cardiac Adverse Reactions With COVID-19 Vaccinations
Cardiac and Neurological Complications Post COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series
Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study
Cardiac side effects of RNA-based SARS-CoV-2 vaccines: Hidden cardiotoxic effects of mRNA-1273 and BNT162b2 on ventricular myocyte function and structure
Cardiopulmonary Arrest After COVID-19 Vaccination: A Case Report
Cardiovascular magnetic resonance imaging and clinical follow-up in patients with clinically suspected myocarditis after COVID-19 vaccination
Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2
Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis
Clinical Considerations: Myocarditis and Pericarditis after Receipt of COVID-19 Vaccines Among Adolescents and Young Adults
Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study
Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures
Correspondence: Myocarditis after Covid-19 mRNA Vaccination
COVID Vaccine Autopsy Reports: Shocking Impact Revealed
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
COVID-19 mRNA Vaccine Induced Pericarditis With Large Pericardial Effusion Followed by New-Onset Arrhythmia
COVID-19 Vaccination-Associated Myocarditis: A Literature Review
COVID-19 Vaccination-Induced Cardiomyopathy Requiring Permanent Left Ventricular Assist Device
COVID-19 Vaccination-Related Myocarditis: What We Learned From Our Experience and What We Need to Do in The Future
COVID-19 Vaccine Safety Technical (VaST) Work Group
COVID-19 vaccine safety update: Primary series in young children and booster doses in older children and adults
COVID-19 Vaccine safety updates - Advisory Committee on Immunization Practices (ACIP)
COVID-19 vaccine weekly safety report
COVID-19 Vaccine-Related Myocarditis: A Descriptive Study of 40 Case Reports
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals
Deciphering deaths associated with severe serious adverse events following SARS-CoV-2 vaccination: A retrospective cohort study
Delayed Vigilance: A Comment on Myocarditis in Association with the COVID-19 Injections
Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination
Load More
Topic ID
1010
© 2023 - 2025
The Covid Index
. All rights reserved.
To Top